# Disclo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/disclo

- Industry: Software
- Headquarters: Dover, US
- Website: www.disclo.com
- Total disclosed funding: $12M
- Latest round: Seed (Feb 1, 2023)
- Investors on record: 4

## About

Based in Dover, US, and founded in 2019, Chronically Capable, Inc. trading name under Disclo, operates as a software platform that engages in management system solutions. In November 2022, Disclo raised USD 6.75 million in seed funding led by General Catalyst Partners, with participation from Bain Capital Ventures, Lerer Hippeau Ventures, and Y Combinator.

Disclo is a HIPAA-compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. The company helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

The company plans to use the November 2022 funding for further product improvement and hire additional team members.

## Funding rounds

- Seed, Feb 1, 2023, $5M — Bain Capital, General Catalyst Partners, Lerer Hippeau Ventures, Y Combinator
- Seed, Nov 21, 2022, $6.8M — Bain Capital, General Catalyst Partners, Lerer Hippeau Ventures, Y Combinator

## Investors

- Bain Capital (https://capitalatlas.ai/funds/bain-capital) — Seed
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Seed
- Lerer Hippeau Ventures — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed